A MEMBER OF GENESIS BIOTECHNOLOGY GROUP Trademark

Trademark Overview

On Wednesday, February 16, 2011, a trademark application was filed for A MEMBER OF GENESIS BIOTECHNOLOGY GROUP with the United States Patent and Trademark Office. The USPTO has given the A MEMBER OF GENESIS BIOTECHNOLOGY GROUP trademark a serial number of 85243597. The federal status of this trademark filing is ABANDONED - AFTER EX PARTE APPEAL as of Tuesday, January 21, 2014. This trademark is owned by Genesis Biotechnology Group, LLC. The A MEMBER OF GENESIS BIOTECHNOLOGY GROUP trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields, specifically relating to molecular diagnostics, such as, Polymerase Chain Reactions, cancer research, such as, cervical, bladder and prostate cancers, women's health research, such as, bacterial vaginosis, herpes simplex virus, human papillomavirus, and gonorrhea, biomarker and novel drug discovery, such as, high throughput screening of new chemical compounds, immunology abnormality, such as, irritable bowel disease and Crohn's disease, antimicrobials research, all of the foregoing goods and services excluding body donation research
a member of genesis biotechnology group

General Information

Serial Number85243597
Word MarkA MEMBER OF GENESIS BIOTECHNOLOGY GROUP
Filing DateWednesday, February 16, 2011
Status603 - ABANDONED - AFTER EX PARTE APPEAL
Status DateTuesday, January 21, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"BIOTECHNOLOGY GROUP"
Description of MarkThe mark consists of the literal elements "A MEMBER OF BIOTECHNOLOGY GROUP" and the stylized term "GENESIS" with a sylized depiction of a molecule consisting of fourteen spheres representing atoms that are connected by straight bands representing bonds wherein the letter "I" in "GENESIS" is represented by a vertical band connecting two atoms.
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields, specifically relating to molecular diagnostics, such as, Polymerase Chain Reactions, cancer research, such as, cervical, bladder and prostate cancers, women's health research, such as, bacterial vaginosis, herpes simplex virus, human papillomavirus, and gonorrhea, biomarker and novel drug discovery, such as, high throughput screening of new chemical compounds, immunology abnormality, such as, irritable bowel disease and Crohn's disease, antimicrobials research, all of the foregoing goods and services excluding body donation research

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 22, 2011
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenesis Biotechnology Group, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHamilton, NJ 08690

Trademark Events

Event DateEvent Description
Wednesday, January 22, 2014ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Tuesday, January 21, 2014ABANDONMENT - AFTER EX PARTE APPEAL
Tuesday, January 21, 2014EXPARTE APPEAL TERMINATED
Thursday, December 5, 2013EXPARTE APPEAL DSMSED - FAILURE TO FILE BRIEF
Tuesday, September 3, 2013NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Tuesday, September 3, 2013SUBSEQUENT FINAL EMAILED
Tuesday, September 3, 2013SUBSEQUENT FINAL REFUSAL WRITTEN
Wednesday, August 7, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 7, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 7, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 7, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 7, 2013NON-FINAL ACTION E-MAILED
Thursday, February 7, 2013NON-FINAL ACTION WRITTEN
Friday, January 25, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 25, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 24, 2013ASSIGNED TO LIE
Tuesday, January 22, 2013TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, January 22, 2013EX PARTE APPEAL-INSTITUTED
Tuesday, January 22, 2013JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, January 22, 2013EXPARTE APPEAL RECEIVED AT TTAB
Sunday, July 22, 2012NOTIFICATION OF FINAL REFUSAL EMAILED
Sunday, July 22, 2012FINAL REFUSAL E-MAILED
Sunday, July 22, 2012FINAL REFUSAL WRITTEN
Thursday, June 7, 2012LIE CHECKED SUSP - TO ATTY FOR ACTION
Thursday, June 7, 2012ASSIGNED TO LIE
Wednesday, December 7, 2011NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, December 7, 2011LETTER OF SUSPENSION E-MAILED
Wednesday, December 7, 2011SUSPENSION LETTER WRITTEN
Wednesday, November 23, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 23, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 23, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 23, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 23, 2011NON-FINAL ACTION E-MAILED
Monday, May 23, 2011NON-FINAL ACTION WRITTEN
Wednesday, May 18, 2011ASSIGNED TO EXAMINER
Wednesday, February 23, 2011NOTICE OF DESIGN SEARCH CODE MAILED
Tuesday, February 22, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, February 19, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

group biotechnology genesis member research such disease screening chemical compounds throughput discovery biomarker gonorrhea